327 related articles for article (PubMed ID: 11992541)
41. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
42. Basigin expression and hormonal regulation in mouse uterus during the peri-implantation period.
Xiao LJ; Chang H; Ding NZ; Ni H; Kadomatsu K; Yang ZM
Mol Reprod Dev; 2002 Sep; 63(1):47-54. PubMed ID: 12211060
[TBL] [Abstract][Full Text] [Related]
43. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.
Jourquin J; Tremblay E; Décanis N; Charton G; Hanessian S; Chollet AM; Le Diguardher T; Khrestchatisky M; Rivera S
Eur J Neurosci; 2003 Sep; 18(6):1507-17. PubMed ID: 14511330
[TBL] [Abstract][Full Text] [Related]
44. HAb18G/CD147 enhances the secretion of matrix metalloproteinases (MMP) via cGMP/NO-sensitive capacitative calcium entry (CCE) and accordingly attenuates adhesion ability of fibroblasts.
Huang Y; Jiang J; Dou K; Chen Z
Eur J Cell Biol; 2005 Jan; 84(1):59-73. PubMed ID: 15724816
[TBL] [Abstract][Full Text] [Related]
45. Expression of Basigin in human fetal, infantile and adult skin and in basal cell carcinoma.
Chen X; Kanekura T; Kanzaki T
J Cutan Pathol; 2001 Apr; 28(4):184-90. PubMed ID: 11426825
[TBL] [Abstract][Full Text] [Related]
46. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
[TBL] [Abstract][Full Text] [Related]
47. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
48. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function.
Toole BP
Curr Top Dev Biol; 2003; 54():371-89. PubMed ID: 12696756
[No Abstract] [Full Text] [Related]
49. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
50. [Expression of extracellular matrix metalloproteinase inducer in human bladder transitional cell carcinoma].
Han JL; Xie WL; Huang J; Yao YS
Ai Zheng; 2003 Nov; 22(11):1158-61. PubMed ID: 14613643
[TBL] [Abstract][Full Text] [Related]
51. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y
Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
[TBL] [Abstract][Full Text] [Related]
52. Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
Voigt H; Houben R; Schrama D; Hofmann UB; Vetter-Kauczok CS; Becker JC
Tumour Biol; 2007; 28(4):229-37. PubMed ID: 17709990
[TBL] [Abstract][Full Text] [Related]
53. Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G/CD147 extracellular domain.
Wang L; Ku XM; Li Y; Bian HJ; Zhang SH; Ye H; Yao XY; Li BH; Yang XM; Liao CG; Chen ZN
Hybridoma (Larchmt); 2006 Apr; 25(2):60-7. PubMed ID: 16704305
[TBL] [Abstract][Full Text] [Related]
54. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions.
Caudroy S; Polette M; Tournier JM; Burlet H; Toole B; Zucker S; Birembaut P
J Histochem Cytochem; 1999 Dec; 47(12):1575-80. PubMed ID: 10567441
[TBL] [Abstract][Full Text] [Related]
55. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.
Gabison EE; Mourah S; Steinfels E; Yan L; Hoang-Xuan T; Watsky MA; De Wever B; Calvo F; Mauviel A; Menashi S
Am J Pathol; 2005 Jan; 166(1):209-19. PubMed ID: 15632013
[TBL] [Abstract][Full Text] [Related]
56. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.
Davidson B; Givant-Horwitz V; Lazarovici P; Risberg B; Nesland JM; Trope CG; Schaefer E; Reich R
Clin Exp Metastasis; 2003; 20(7):621-31. PubMed ID: 14669793
[TBL] [Abstract][Full Text] [Related]
57. Developmental analyses of 5A11/Basigin, 5A11/Basigin-2 and their putative binding partner MCT1 in the mouse eye.
Clamp MF; Ochrietor JD; Moroz TP; Linser PJ
Exp Eye Res; 2004 Apr; 78(4):777-89. PubMed ID: 15037112
[TBL] [Abstract][Full Text] [Related]
58. TRAF6 regulates melanoma invasion and metastasis through ubiquitination of Basigin.
Luo Z; Zhang X; Zeng W; Su J; Yang K; Lu L; Lim CB; Tang W; Wu L; Zhao S; Jia X; Peng C; Chen X
Oncotarget; 2016 Feb; 7(6):7179-92. PubMed ID: 26769849
[TBL] [Abstract][Full Text] [Related]
59. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
[TBL] [Abstract][Full Text] [Related]
60. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
